Patents by Inventor Paul H. SONG

Paul H. SONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXATECAN DERIVATIVES, LINKER-PAYLOADS, AND CONJUGATES AND THEREOF
    Publication number: 20250064957
    Abstract: The present disclosure relates to the biopharmaceutical field, in particular, Exatecan derivatives, linker-payloads, and conjugates and thereof antibody-drug conjugates, and the corresponding preparing process and use thereof.
    Type: Application
    Filed: November 15, 2022
    Publication date: February 27, 2025
    Inventors: Gang QIN, Tony Yantao ZHANG, Guangming CHEN, Paul H. SONG, Mingyu HU, Boyu ZHONG
  • Antibody, Linkers, Payload, Conjugates and Applications Thereof
    Publication number: 20250064953
    Abstract: The present disclosure relates to an antibody, a payload and a linker molecule for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof.
    Type: Application
    Filed: March 28, 2024
    Publication date: February 27, 2025
    Inventors: Dong Yang, Mingyu Hu, Yajun Sun, Paul H. Song, Hanwen Xu, Gang Qin
  • ANTIBODY-CYTOKINE FUSION PROTEINS AND APPLICATIONS THEREOF
    Publication number: 20250043005
    Abstract: Provided are antibody-cytokine fusion proteins comprising an anti-PD-L1 antibody and an Interleukin 21, and methods for preparing the same, as well as applications of the fusion proteins for therapeutic purpose.
    Type: Application
    Filed: December 8, 2022
    Publication date: February 6, 2025
    Inventors: Gang QIN, Paul H. SONG, Dong YANG, Cao LV
  • Anti-HER2 Antibody-Immune Agonist Conjugate and Applications Thereof
    Publication number: 20240181072
    Abstract: The disclosure relates to a linking unit molecule for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof, and in particular relates to an anti-HER2 antibody-immune agonist conjugate (AIAC) as a novel type of cancer therapy.
    Type: Application
    Filed: March 7, 2022
    Publication date: June 6, 2024
    Inventors: Paul H. SONG, Gang QIN, Jiandong YUAN, Chong LIU
  • Exatecan derivatives, linker-payloads, and conjugates and thereof
    Patent number: 11999748
    Abstract: The present disclosure relates to the biopharmaceutical field, in particular, Exatecan derivatives, linker-payloads, and conjugates and thereof antibody-drug conjugates, and the corresponding preparing process and use thereof.
    Type: Grant
    Filed: August 22, 2023
    Date of Patent: June 4, 2024
    Assignee: GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.
    Inventors: Gang Qin, Tony Yantao Zhang, Guangming Chen, Paul H. Song, Boyu Zhong, Mingyu Hu
  • LINKERS, CONJUGATES AND APPLICATIONS THEREOF
    Publication number: 20240066141
    Abstract: The present disclosure relates to a linker molecule for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof.
    Type: Application
    Filed: September 8, 2023
    Publication date: February 29, 2024
    Inventors: Gang QIN, Paul H. SONG, Mingyu HU
  • EXATECAN DERIVATIVES, LINKER-PAYLOADS, AND CONJUGATES AND THEREOF
    Publication number: 20240018159
    Abstract: The present disclosure relates to the biopharmaceutical field, in particular, Exatecan derivatives, linker-payloads, and conjugates and thereof antibody-drug conjugates, and the corresponding preparing process and use thereof.
    Type: Application
    Filed: August 22, 2023
    Publication date: January 18, 2024
    Inventors: Gang QIN, Tony Yantao ZHANG, Guangming CHEN, Paul H. SONG, Boyu ZHONG, Mingyu HU
  • Linkers, conjugates and applications thereof
    Patent number: 11826432
    Abstract: The present disclosure relates to a linker molecule for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof.
    Type: Grant
    Filed: April 14, 2022
    Date of Patent: November 28, 2023
    Assignee: GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.
    Inventors: Gang Qin, Paul H. Song, Mingyu Hu
  • ANTIBODY-IMMUNE AGONIST CONJUGATE AND APPLICATIONS THEREOF
    Publication number: 20230372511
    Abstract: The present disclosure relates to a linking unit molecule for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof, and in particular relates to an antibody-immune agonist conjugate (AIAC) as a novel type of cancer therapy.
    Type: Application
    Filed: August 7, 2023
    Publication date: November 23, 2023
    Inventors: Paul H. SONG, Gang QIN, Chong LIU
  • Exatecan derivatives, linker-payloads, and conjugates and thereof
    Patent number: 11814394
    Abstract: The present disclosure relates to the biopharmaceutical field, in particular, Exatecan derivatives, linker-payloads, and conjugates and thereof antibody-drug conjugates, and the corresponding preparing process and use thereof.
    Type: Grant
    Filed: November 8, 2022
    Date of Patent: November 14, 2023
    Assignee: GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.
    Inventors: Gang Qin, Tony Yantao Zhang, Guangming Chen, Paul H. Song, Boyu Zhong, Mingyu Hu
  • EXATECAN DERIVATIVES, LINKER-PAYLOADS, AND CONJUGATES AND THEREOF
    Publication number: 20230271977
    Abstract: The present disclosure relates to the biopharmaceutical field, in particular, Exatecan derivatives, linker-payloads, and conjugates and thereof antibody-drug conjugates, and the corresponding preparing process and use thereof.
    Type: Application
    Filed: November 8, 2022
    Publication date: August 31, 2023
    Inventors: Gang QIN, Tony Yantao ZHANG, Guangming CHEN, Paul H. SONG, Boyu ZHONG, Mingyu HU
  • Antibody-immune agonist conjugate and applications thereof
    Patent number: 11717576
    Abstract: The present disclosure relates to a linking unit molecule for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof, and in particular relates to an antibody-immune agonist conjugate (AIAC) as a novel type of cancer therapy.
    Type: Grant
    Filed: March 8, 2022
    Date of Patent: August 8, 2023
    Assignee: GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.
    Inventors: Paul H. Song, Gang Qin, Chong Liu
  • LINKERS, CONJUGATES AND APPLICATIONS THEREOF
    Publication number: 20220395581
    Abstract: The present disclosure relates to a linker molecule for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof.
    Type: Application
    Filed: April 14, 2022
    Publication date: December 15, 2022
    Inventors: Gang QIN, Paul H. SONG, Mingyu HU
  • ANTIBODY-IMMUNE AGONIST CONJUGATE AND APPLICATIONS THEREOF
    Publication number: 20220378930
    Abstract: The present disclosure relates to a linking unit molecule for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof, and in particular relates to an antibody-immune agonist conjugate (AIAC) as a novel type of cancer therapy.
    Type: Application
    Filed: March 8, 2022
    Publication date: December 1, 2022
    Inventors: Paul H. SONG, Gang QIN, Chong LIU